FdaApplication
ANDA 218272
Identifiers
- fda_app_no: ANDA218272
Properties
| Property | Value |
|---|---|
| applicant_name | ASPIRO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2024-11-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | INJECTABLE;INJECTION |
1 product